T Central Memory Cells in Early Localized Non-Segmental Vitiligo
NCT ID: NCT05706636
Last Updated: 2025-04-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
22 participants
INTERVENTIONAL
2023-02-01
2025-04-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Early Systemic Stabilization Therapy on Recent Onset Vitiligo
NCT05037981
Comparison Between Systemic Steroids, Topical Steroids, or Calcineurin Inhibitors With Mini Punch Grafting in Treatment of Stable Non-segmental Vitiligo
NCT04765826
Efficacy of Autologous Outer-Root-Sheath Melanocytes Transplantation in the Treatment of Vitiligo
NCT01923142
The Value of Using Mini-oral Pulse Steroid Therapy Along With Non Cultured Epidermal Cell Suspension (NCES) in Stable Resistant Vitiligo
NCT06974669
Improved Phototherapy in Patients With Vitiligo
NCT05836441
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Early localized vitiligo on topical treatment
Cases will only receive topical steroids/ calcineurin inhibitors and targeted phototherapy
Topical cream
topical fluticasone cream for body lesions and topical tacrolimus for face lesions
targeted phototherapy
twice weekly targeted excimer light sessions
Early localized vitiligo on topical and systemic treatment
Cases will receive oral mini-pulse steroids, topical steroids/ calcineurin inhibitors and targeted phototherapy
oral mini pulse
5mg / week oral dexamethasone
Topical cream
topical fluticasone cream for body lesions and topical tacrolimus for face lesions
targeted phototherapy
twice weekly targeted excimer light sessions
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
oral mini pulse
5mg / week oral dexamethasone
Topical cream
topical fluticasone cream for body lesions and topical tacrolimus for face lesions
targeted phototherapy
twice weekly targeted excimer light sessions
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
12 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rania Mogawer
principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Samia Esmat, MD
Role: STUDY_CHAIR
Cairo University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cairo university hospitals, dermatology outpatient clinic
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
V-1-23
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.